跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Saxagliptin (As Hydrochloride) - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Saxagliptin (As Hydrochloride)
Approved
STANDARD
Saxagliptin (As Hydrochloride)
AstraZeneca Pharmaceuticals LP
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
20e71c0a33a57e8d
Company
AstraZeneca Pharmaceuticals LP
Type
Standard
Approval Details
Approval Id
20e71c0a33a57e8d
Drug Approval Philippines Name
Saxagliptin (As Hydrochloride)
Product Name
Saxagliptin (As Hydrochloride)
Registration Number
DR-XY38015
Brand Name
Saxagliptin (As Hydrochloride)
Generic Name
Onglyza
Dosage Form
Film-Coated Tablet
Dosage Strength
5 mg
Manufacturer
AstraZeneca Pharmaceuticals LP
Trader
AstraZeneca UK Limited
Importer
AstraZeneca Pharmaceutical (Phils.), Inc.
Company Detail Path
/organization/astrazeneca-pharmaceuticals-lp
Trader Detail Path
/organization/astrazeneca-uk-limited
Issuance Date
27 January 2021
Expiry Date
04 March 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
20e71c0a33a57e8d
Type
Standard
Back to Philippines FDA Approvals